No effective therapy has yet developed for liver fibro-Among the different causes of liver cirrhosis, one sis by directory inhibiting the accumulation of extracelcommon feature is an increased deposition of extracellular matrix. The effect of a newly synthesized prolyl lular matrix, which consists m
Coexpression of the lysyl oxidase-like gene (LOXL) and the gene encoding type III procollagen in induced liver fibrosis
โ Scribed by Youngho Kim; Simone Peyrol; Chi-Kwong So; Charles D. Boyd; Katalin Csiszar
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 526 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
โฆ Synopsis
We have isolated a mouse lysyl oxidase-like (LOXL) cDNA from a mouse embryo cDNA library and used this cDNA to measure changes in steady state levels of LOXL mRNA during the development of carbon tetrachloride-induced liver fibrosis in adult mice. These results revealed the coincident appearance of increased steady state levels of LOXL mRNA and type III procollagen mRNA early in the development of liver fibrosis. In contrast, steady state levels of lysyl oxidase mRNA increased throughout the onset of hepatic fibrosis and appeared in parallel with the increased steady state levels of pro-alphaI (I) collagen mRNA. These findings suggest that the LOXL protein (possibly an isoform of lysyl oxidase) is involved in the development of lysine-derived cross-links in collagenous substrates. Moreover, the substrate specificity of the LOXL protein may be different to that of lysyl oxidase and this difference may be collagen-type specific.
๐ SIMILAR VOLUMES